September 25, 2026 | Murcia, Spain The NANEMIAR team, part of the Murcian Institute of Biosanitary Research (IMIB), participated in the European Researchers’ Night 2026, one of Europe’s largest science outreach events, promoted by the European Commission within the framework of the Marie Skłodowska-Curie Actions of the Horizon Europe programme. On ...
News & Events
In this next interview Dr. Jurgen Dieker, CSO at Mercurna (Netherlands) shares with us his personal experience working in a biotech start-up and reveals what motivates to co-found Mercurna. Dr. Jurgen Dieker, CSO at Mercurna who is a beneficiary of the NANEMIAR Project, explains to us what his role is within NANEMIAR. Hi, Jurgen! Thank you very muc...
NANEMIAR are participating in the European Hematology Association Congress (EHA 2026), one of the most important international scientific meetings in the field of hematology. Dr. Perez-Oliva was invited as a speaker in today's session, "Inflammasome in Congenital Anemias", where she delivered a presentation entitled "Inflammasome and Its Implicatio...
In this new NANEMIAR interview, we spoke with Léa Girondier (CNRS), a researcher in the project, who shares her experience in the development of new therapeutic strategies for congenital anemias. Throughout the conversation, she explains her role in conducting experiments using ex vivo and in vivo models, the technical challenges involved in optimi...
The session featured the participation of Dr. Ana Belén Pérez Oliva, who presented the advances and possibilities offered by lipid nanoparticles for delivering gene therapies and therapeutic molecules directly to affected blood cells. This technology represents one of the most promising approaches within personalized medicine and nanotechnology app...